We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 28,127

FTC Recommends Ways to Increase Competition and Stimulate Growth in Biosimilars and Interchangeable Market
  • Duane Morris LLP
  • USA
  • August 13 2018

The Federal Trade Commission (FTC) recently provided comments on the Department of Health and Human Services' (HHS) Blueprint to Lower Drug Prices and


FDA Publishes Draft Guidance for Field Alert Report Submission
  • Duane Morris LLP
  • USA
  • August 13 2018

All applicants of new drug applications (NDAs) and abbreviated new drug applications (ANDAs) are required to submit Field Alert Reports (FARs) for


FDA Publishes Draft Guidance Seeking Innovative Approaches for Nonprescription Drug Product Labeling and Additional Conditions for Use
  • Duane Morris LLP
  • USA
  • August 13 2018

In an effort to provide approval of a wider range of nonprescription drug products, the U.S. Food and Drug Administration (FDA) has issued a draft


Manufacturer held liable for asbestos-related injury stemming from replacement parts it did not make.
  • Sidley Austin LLP
  • USA
  • August 13 2018

A New Jersey appeals court has ruled that manufacturers of products with asbestos-containing components have a duty to warn users of replacement parts


Can almonds lactate? Standards of identity and why the FDA may soon target makers of milk substitutes
  • Thompson Coburn LLP
  • USA
  • August 13 2018

“Standards of identity” are used by the FDA to establish the common or usual name of certain processed foods and define their basic nature. A standard


NAD Sheds Light on Comparisons Against “Regular” Products
  • Kelley Drye & Warren LLP
  • USA
  • August 10 2018

Advertisers who want to tout the comparative advantages of their products have a number of options for framing those comparisons. For example, they


Trader Joe’s Alkaline Water Gets the Class Action Hose
  • Baker & Hostetler LLP
  • USA
  • August 10 2018

Cali consumer says health benefit claims and pH levels are out of whack


UK Product Safety Regulator publishes detailed strategy for the future - opportunities and challenges for innovative companies
  • Cooley LLP
  • USA, United Kingdom, OECD, European Union
  • August 10 2018

Today, the new UK Office for Product Safety and Standards (OPSS) published its detailed strategy paper, outlining its plans and priorities for its


The true cost of regional product adaptation: why emerging regulations concerning local formulations of product could shake consumer confidence in global household brands
  • Osborne Clarke
  • United Kingdom
  • August 10 2018

Many global brands use different formulations to account for local taste to ensure their product is a success in regional markets. However the


Former Director of the FDA’s Office of Biotechnology Pens Op-Ed Criticizing FDA Enforcement on Organic Labeling, FDA Commissioner Pledges to Look at Labeling Claims in Organics
  • Keller and Heckman LLP
  • USA
  • August 10 2018

In a Wall Street Journal op-ed, Dr. Henry Miller, the former founding director of the FDA’s Office of Biotechnology, criticizes FDA as giving organic